Biotech ex­ecs slam Trump’s trav­el ban, count­ing the high cost to a glob­al in­dus­try

A large ma­jor­i­ty of the biotech in­dus­try has ve­he­ment­ly re­ject­ed Don­ald Trump’s trav­el ban in no un­cer­tain terms.

!func­tion(e,t,n,s){var i=”In­fo­gramEm­beds”,o=e.getEle­ments­By­Tag­Name(t),d=o[0],a=/^http:/.test(e.lo­ca­tion)?”http:”:”https:”;if(/^\/{2}/.test(s)&&(s=a+s),win­dow[i]&&win­dow[i].ini­tial­ized)win­dow[i].process&&win­dow[i].process();else if(!e.getEle­ment­ById(n)){var r=e.cre­ateEle­ment(t);r.async=1,r.id=n,r.src=s,d.par­entN­ode.in­sert­Be­fore(r,d)}}(doc­u­ment,”script”,”in­fo­gram-async”,”//e.in­fo­gr.am/js/dist/em­bed-loader-min.js”);

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER